Thermo Fisher Scientific delivered an excellent result surpassing Wall Street expectations in terms of both, revenues as well as earnings. The world's largest maker of scientific instruments benefitted heavily from the surge in the number of Covid-19 cases resulting from the spread of the Delta variant. Thermo Fisher generated $2.05 billion in the form of Covid-19 response revenue in the third quarter, which includes sales related to vaccines and therapies as well as diagnostic testing. The comp ....
09 Nov 2021
Thermo Fisher Scientific Inc. - Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation 11/09
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Thermo Fisher Scientific Inc. - Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation 11/09
- Published:
09 Nov 2021 -
Author:
Ishan Majumdar -
Pages:
14
Thermo Fisher Scientific delivered an excellent result surpassing Wall Street expectations in terms of both, revenues as well as earnings. The world's largest maker of scientific instruments benefitted heavily from the surge in the number of Covid-19 cases resulting from the spread of the Delta variant. Thermo Fisher generated $2.05 billion in the form of Covid-19 response revenue in the third quarter, which includes sales related to vaccines and therapies as well as diagnostic testing. The comp ....